Cite
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies
MLA
Alexandra Loew-Baselli, et al. “Safety and Immunogenicity of the Modified Adult Tick-Borne Encephalitis Vaccine FSME-IMMUN: Results of Two Large Phase 3 Clinical Studies.” Vaccine, vol. 24, no. 24, June 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cc306d71f86fdf2af94aa3548affaf31&authtype=sso&custid=ns315887.
APA
Alexandra Loew-Baselli, Eva-Maria Poellabauer, P N Barrett, Sandor Fritsch, M Krammer, Friedrich Maritsch, P Harmacek, R Konior, Borislava G. Pavlova, & Hartmut J. Ehrlich. (2005). Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. Vaccine, 24(24).
Chicago
Alexandra Loew-Baselli, Eva-Maria Poellabauer, P N Barrett, Sandor Fritsch, M Krammer, Friedrich Maritsch, P Harmacek, R Konior, Borislava G. Pavlova, and Hartmut J. Ehrlich. 2005. “Safety and Immunogenicity of the Modified Adult Tick-Borne Encephalitis Vaccine FSME-IMMUN: Results of Two Large Phase 3 Clinical Studies.” Vaccine 24 (24). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cc306d71f86fdf2af94aa3548affaf31&authtype=sso&custid=ns315887.